Daniela Olivera-Parente
Family · Boca Raton, FLNPI 1114439726
Payments from drug & device makers
Across 156 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$581
- Lilly USA, LLC$479
- Bayer$326
- Exact Sciences$238
- Novo Nordisk$218
- GSK$149
- plus $797 from 22 others
What the payments were for
- Food & beverage$2,789100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 38 | $581 |
| Lilly USA, LLC | 26 | $479 |
| Bayer | 19 | $326 |
| Exact Sciences | 11 | $238 |
| Novo Nordisk | 11 | $218 |
| GSK | 9 | $149 |
| Boehringer Ingelheim | 8 | $133 |
| Amarin Pharma, Inc. | 4 | $74 |
| Idorsia Pharmaceuticals US Inc | 4 | $68 |
| AbbVie | 3 | $66 |
| Sonex Health, Inc. | 1 | $53 |
| Eisai Inc. | 2 | $42 |
| Pfizer | 2 | $39 |
| Dexcom, Inc. | 2 | $37 |
| Phadia US Inc. | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Almatica Pharma LLC | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Mannkind Corporation | 1 | $21 |
| Novartis | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Merck | 1 | $16 |
| AstraZeneca | 1 | $15 |
| TMS Neurohealth Centers Inc. | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Medicure Pharma Inc. | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $12 |
How this compares
$2,789 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $16,189 |
| OzempicSemaglutide | 11 | $14,251 |
| TrulicityDulaglutide | 12 | $11,664 |
| SynthroidLevothyroxine Sodium | 13 | $1,388 |
| Rosuvastatin Calcium | 143 | $1,210 |
| Atorvastatin Calcium | 93 | $722 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $668 |
| Levothyroxine Sodium | 66 | $647 |
| ValacyclovirValacyclovir Hcl | 18 | $545 |
| Amlodipine Besylate | 96 | $461 |
| Sertraline Hcl | 41 | $459 |
| Quetiapine Fumarate | 32 | $454 |
| Lisinopril | 51 | $410 |
| Valsartan | 11 | $376 |
| Omeprazole | 36 | $364 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $39 | $16,18916 claims |
| Novo NordiskOzempic | $218 | $14,25111 claims |
| Lilly USA, LLCTrulicity | $479 | $11,66412 claims |
| AbbVieSynthroid | $66 | $1,38813 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $12 | $64766 claims |
| Almatica Pharma LLCSertraline Hcl | $23 | $45941 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 14,618 family providers in Florida.
Other family in Boca Raton
- Kate GoldbergBoca Raton$57K
- Kettia Alusma HibbertBoca Raton$52K
- Karen KlugeBoca Raton$45K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.